Actively Recruiting
Remimazolam vs. Propofol: Impact on Postoperative Delirium in Neurosurgical Patients
Led by Samsung Medical Center · Updated on 2024-04-17
696
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigator aimed to evaluate the incidence of postoperative delirium after remimazolam-based total intravenous anestheisa (TIVA) compared to the propofol-based TIVA in patients undergoing neurosurgery.
CONDITIONS
Official Title
Remimazolam vs. Propofol: Impact on Postoperative Delirium in Neurosurgical Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- American Society of Anesthesiologists (ASA) class I to III patients
You will not qualify if you...
- Severe respiratory, cardiovascular, or liver disease (Child-Pugh class C)
- Dependency on psychiatric drugs or alcohol
- Severe sensory impairments that interfere with communication
- Presence of delirium before surgery
- Allergies, hypersensitivity, or contraindications to remimazolam or propofol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Samsung Medical Center
Seoul, South Korea, 06351
Actively Recruiting
Research Team
J
jeayoun kim
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here